Cantilever Opportunity Fund, LP
Overview
Cantilever Opportunity Fund, LP is a venture capital investment firm that seeks to invest in the biotechnology and diagnostics, drug discovery, medical devices, business productivity, and consumer and professional services sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Peptinovo Biopharma | Jan 2026 | Series A | Lead |
| Light Line Medical | Oct 2023 | Series A | Co-investor |
| StabiLux Biosciences | - | SAFE | Co-investor |
Key People
Steve Tokarz
General and Managing Partner, Founder, General and Managing Partner
Michael Mortlock
Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cantilever Opportunity Fund, LP based?
Cantilever Opportunity Fund, LP is headquartered in Ann Arbor, Michigan, United States.
When was Cantilever Opportunity Fund, LP founded?
Cantilever Opportunity Fund, LP was founded in 2016.
How many portfolio companies does Cantilever Opportunity Fund, LP have?
Cantilever Opportunity Fund, LP has 3 portfolio companies in Caplight's dataset.
What are some companies in Cantilever Opportunity Fund, LP's portfolio?
Portfolio companies visible on Caplight include Peptinovo Biopharma, Light Line Medical, StabiLux Biosciences.
What was Cantilever Opportunity Fund, LP's most recent investment shown here?
Cantilever Opportunity Fund, LP's most recent investment in this portfolio sample was in Peptinovo Biopharma in 2026.
What sectors does Cantilever Opportunity Fund, LP focus on?
Cantilever Opportunity Fund, LP focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Cantilever Opportunity Fund, LP focus on?
Cantilever Opportunity Fund, LP typically invests at the Early stage.